Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension

NCT02216279 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.

NCT NCT02216279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02216279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension
Lead sponsor
Montreal Heart Institute
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2014
Completion date
September 30, 2015
Enrollment
45 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension